Renal crystal formation after combined or sequential oral administration of melamine and cyanuric acid

Food and Chemical Toxicology

Volumn 48, Issue 10, 2010, Pages 2898-2906

  Reimschuessel, R ^a   Evans, E R ^a   Stine, C B ^a   Hasbrouck, N ^a   Mayer, T D ^a   Nochetto, C ^a   Gieseker, C M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Crystal; Cyanuric acid; Fish; Kidney; Melamine; No observable adverse effect level

Indexed keywords

CYANURIC ACID; MELAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATFISH; CONTROLLED STUDY; CRYSTALLIZATION; EXCRETION; HISTOPATHOLOGY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; NONHUMAN; RAINBOW TROUT; RENAL CRYSTAL; TOXICITY TESTING;

ANIMALS; CRYSTALLIZATION; FOOD CONTAMINATION; ICTALURIDAE; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ONCORHYNCHUS MYKISS; TRIAZINES;

MAMMALIA; SALMONIDAE;

EID: 77956340606     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.07.024     Document Type: Article

References (88)

1. Anon, 2008. The Government of Canada responds to reports of melamine in food products. Health Canada. Available at: (accessed 12.03.10). http://www.hc-sc.gc.ca/fn-an/securit/chem-chim/melamine/index-eng.php.
2. AQSIQ Five Departments Regulated Melamine Limits in Milk Products for the First Time 2008, General Administration of Quality Supervision, Inspection and Quarantine, China.
3. AVMA Guidelines on Euthanasia, 2007. Available at: (accessed 12.03.10). http://www.avma.org/issues/animal_welfare/euthanasia.pdf.
4. Bailey G.S., Williams D.E., Hendricks J.D. Fish models for environmental carcinogenesis: the rainbow trout. Environ. Health Perspect. 1996, 104(1):5-21.
5. Barboza, D., Barrioneuvo, A., 2007. Filler in Animal Feed Is Open Secret in China. New York Times. Available at: (accessed 12.03.10). http://www.nytimes.com/2007/04/30/business/worldbusiness/30food.html.
6. Barboza, D., 2008. Asia Food Tainting Spreads, Leading to Recall in US. New York Times. Available at: (accessed 12.03.10). http://www.nytimes.com/2008/09/27/world/asia/27recall.html.
7. Bassett D.I., Currie P.D. The zebrafish as a model for muscular dystrophy and congenital myopathy. Hum. Mol. Genet. 2003, 5(12):265-270.
8. Bhalla V., Grimm P.C., Chertow G.M., Pao A.C. Melamine nephrotoxicity: an emerging epidemic in an era of globalization. Kidney Int. 2009, 75(8):774-779.
9. Bradsher, K., 2008. China Begins Inquiry into Tainted Baby Formula. New York Times. Available at: (accessed 12.03.10). http://www.nytimes.com/2008/09/13/world/asia/13milk.html?hp.
10. Brown C.A., Jeong K.S., Poppenga R.H., Puschner B., Miller D.M., Ellis A.E., Kang K.I., Sum S., Cistola A.M., Brown S.A. Outbreaks of renal failure associated with melamine and cyanuric acid in dogs and cats in 2004 and 2007. J. Vet. Diagn. Invest. 2007, 19(5):525-531.
11. Carradice D., Lieschke G.J. Zebrafish in hematology: sushi or science?. Blood 2008, 111(7):3331-3342.
12. Centre for Food Safety, The Government of the Hong Kong Special Administrative Region, 2008. Available at: (accessed 12.03.10). http://www.cfs.gov.hk/english/whatsnew/whatsnew_fstr/whatsnew_fstr_Test_dairy_product_FAQ.html.
13. Chen K.C., Liao C.W., Cheng F.P., Chou C.C., Chang S.C., Wu J.H., Zen J.M., Chen Y.T., Liao J.W. Evaluation of subchronic toxicity of pet food contaminated with melamine and cyanuric acid in rats. Toxicol. Pathol. 2009, 37(7):959-968.
14. Chiu M.C. Melamine-tainted milk product (MTMP) renal stone outbreak in humans. Hong Kong Med. J. 2008, 14:424-426.
15. Cianciolo R.E., Bischoff K., Ebel J.G., Van Winkle T.J., Goldstein R.E., Serfilippi L.M. Clinicopathologic, histologic, and toxicologic findings in 70 cats inadvertently exposed to pet food contaminated with melamine and cyanuric acid. J. Am. Vet. Med. Assoc. 2008, 233(5):729-737.
16. Cohen, S.M., McKinney, L., Wagner, B.M., Weil, C., Goodman, J.I., Lotti, M., Portoghese, P., Bernard, B.K., 1999. An Evaluation of the Long-term Toxicity/Carcinogenicity of Sodium Isocyanurate (No. 44834403) (Submitted as Unpublished Report 25 February 1999 to Occidental Chemical Corporation, provided to US, EPA. Submitted to WHO by the Industry Ad Hoc Committee on Isocyanurates).
17. Conger J.D., Falk S.A., Guggenheim S.J., Burke T.J. A micropuncture study of the early phase of acute urate nephropathy. J. Clin. Invest. 1976, 58(3):681-689.
18. Conger J.D. Acute uric acid nephropathy. Med. Clin. North Am. 1990, 74(4):859-871.
19. Commission of the European Communities. COMMISSION DECISION of 26 September 2008 Imposing Special Conditions Governing the Import of Products Containing Milk or Milk Products Originating in or Consigned from China. Official Journal of the European Union September 2008. Available at: (accessed 12.03.10). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:259:0010:0011:EN:PDF.
20. Cremonezzi D.C., Silva R.A., del Pilar Diaz R.A., Valentich M.A., Eynard A.R. Dietary polyunsaturated fatty acids (PUFA) differentially modulate melamine-induced preneoplastic urothelial proliferation and apoptosis in mice. PLEFA 2001, 64(3):151-159.
21. Cremonezzi D.C., Díaz M.P., Valentich M.A., Eynard A.R. Neoplastic and preneoplastic lesions induced by melamine in rat urothelium are modulated by dietary polyunsaturated fatty acids. Food Chem. Toxicol. 2004, 42(12):1999-2007.
22. Dahme T., Katus H.A., Rottbauer W. Fishing for the genetic basis of cardiovascular disease. Dis. Model Mech. 2009, 2(1-2):18-22.
23. Dobson R.L.M., Motlagh S., Quijano M., Cambron R.T., Baker T.R., Pullen A.M., Regg B.T., Bigalow-Kern A.S., Vennard T., Fix A., Reimschuessel R., Overmann G., Shan Y., Daston G.P. Identification and characterization of toxicity of contaminants in pet food leading to an outbreak of renal toxicity in cats and dogs. J. Toxicol. Sci. 2008, 106(1):251-262.
24. Dodd A., Curtis P.M., Williams L.C., Love D.R. Zebrafish: bridging the gap between development and disease. Hum. Mol. Genet. 2000, 9(16):2443-2449.
25. Drummond I.A. Kidney development and disease in the zebrafish: review. J. Am. Soc. Nephrol. 2005, 16(2):299-304.
26. Dubois-Dalcq M., Williams A., Stadelmann C., Stankoff B., Zalc B., Lubetzki C. From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases: review. Brain 2008, 131(7):1686-1700.
27. Feitsma H., Cuppen E. Zebrafish as a cancer model: review. Mol. Cancer Res. 2008, 6(5):685-694.
28. Goessling W., North T.E., Zon L.I. New waves of discovery: modeling cancer in zebrafish: review. J. Clin. Oncol. 2007, 25(17):2473-2479.
29. Grases F., Costa-Bauzá A., Gomila I., Serra-Trespalle S., Alonso-Sainz F., del Valle J.M. Melamine urinary bladder stone. Urology 2009, 73(6):1262-1263.
30. Guan N., Fan Q., Ding J., Zhao Y., Lu J., Ai Y., Xu G., Zhu S., Yao C., Jiang L., Miao J., Zhang H., Zhao D., Liu X., Yao Y. Melamine-contaminated powdered formula and urolithiasis in young children. N. Eng. J. Med. 2009, 360(11):1067-1073.
31. Hard G.C., Flake G.P., Sills R.C. Re-evaluation of kidney histopathology from 13-week toxicity and two-year carcinogenicity studies of melamine in the F344 rat: morphologic evidence of retrograde nephropathy. Vet. Pathol. 2009, 46(6):1248-1257.
32. Heck H.D., Tyl R.W. The induction of bladder stones by terephthalic acid, dimethyl terephthalate, and melamine (2,4,6-triamino-s-triazine) and its relevance to risk assessment. Regul. Toxicol. Pharm. 1985, 5(3):294-313.
33. Heller D.N., Nochetto C.B. Simultaneous determination and confirmation of melamine and cyanuric acid in animal feed by zwitterionic hydrophilic interaction chromatography and tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2008, 22:3624-3632.
34. Hill A.J., Teraoka H., Heideman W., Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity: review. Toxicol. Sci. 2005, 86(1):6-19.
35. Hodge H.C., Panner B.J., Downs W.L., Maynard E.A. Toxicity of sodium cyanurate. Toxicol. Appl. Pharmacol. 1965, 7:667-674.
36. Hu P., Lu L., Hu B., Zhang C.R. The size of melamine-induced stones is dependent on the melamine content of the formula fed, but not on duration of exposure. Pediatr. Nephrol. 2010, 25(3):565-566.
37. IUCLID, 2000a. Chemical Dataset for Cyanuric Acid (International Uniform Chemical Information Database) Dataset Created by European Commission, European Chemicals Bureau.
38. IUCLID, 2000b. Chemical Dataset for Melamine (International Uniform Chemical Information Database) Dataset Created by European Commission, European Chemicals Bureau.
39. Jia L., Shen Y., Wang X., He L., Xin Y., Hu Y. Ultrasonographic diagnosis of urinary calculus caused by melamine in children. Chin. Med. J. 2009, 122(3):252-256.
40. Kari G., Rodeck U., Dicker A.P. Zebrafish: an emerging model system for human disease and drug discovery: review. Clin. Pharmacol. Ther. 2007, 82(1):70-80.
41. Keller E.T., Murtha J.M. The use of mature zebrafish (Danio rerio) as a model for human aging and disease: review. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 2004, 138(3):335-341.
42. Kim C.W., Yun J.W., Bae I.H., Lee J.S., Kang H.J., Joo K.M., Jeong H.J., Chung J.H., Park Y.H., Lim K.M. Determination of spatial distribution of melamine-cyanuric acid crystals in rat kidney tissue by histology and imaging matrix-assisted laser desorption/ionization quadrupole time-of-flight mass spectrometry. Chem. Res. Toxicol. 2010, 23(1):220-227.
43. Kuehn B.M. Melamine scandals highlight hazards of increasingly globalized food chain. J. Am. Med. Assoc. 2009, 301(5):473-475.
44. Lam, C.W., Lan, L., Che, X., Tam, S., Wong, S.S., Chen, Y., Jin, J., Tao, S.H., Tang, X.M., Yuen, K.Y., Tam, P.K., 2009. Diagnosis and spectrum of melamine-related renal disease: plausible mechanism of stone formation in humans. Clin. Chim. Acta 402(1-2), 150-155.
45. Lau H.Y., Wong C.S., Ma J.K., Kan E., Siu K.L. US findings of melamine-related renaldisorders in Hong Kong children. Pediatr. Radiol. 2009, 39(11):1188-1193.
46. Luengyosluechakul S. Evidence of melamine and related substances contamination to animal feed in Thailand. Thai J. Vet. Med. 2007, 37(4):7-8.
47. Marshall E.K., Grafflin A.L. The structure and function of the kidney of Lophius pisatorius. Bull. Johns Hopkins Hosp. 1928, 43:205.
48. Melnick R.L., Boorman G.A., Haseman J.K., Montali R.J., Huff J. Urolithiasis and bladder carcinogenicity of melamine in rodents. Toxicol. Appl. Pharmacol. 1984, 72(2):292-303.
49. New Zealand Food Safety Authority, 2008. NZFSA Refines Melamine Response Approach. Available at: (accessed 12.03.10). http://www.nzfsa.govt.nz/publications/media-releases/2008/29-sep-melamine-statement.htm.
50. NTP, 1983. Carcinogenesis Bioassay of Melamine (CAS No. 108-78-1) in F344/N Rats and B6C3F1 Mice (Feed Study). United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program, Research Triangle Park, NC, and Bethesda, MD (NTP TR 245; NTP-81-86; NIH Publication No. 83-2501). Available at: (accessed 12.03.10). http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr245.pdf.
51. OECD, 1998. Screening Information Dataset (SIDS) for Melamine. (CAS No. 108-78-1) Paris: Organisation for Economic Co-operation and Development. Available at: (accessed 12.03.10). http://www.inchem.org/documents/sids/sids/108781.pdf.
52. OECD, 1999. Screening Information Dataset (SIDS) for Isocyanuric Acid. (CAS No. 108-80-5) Paris: Organisation for Economic Co-operation and Development. Available at: (accessed 12.03.10). http://www.chem.unep.ch/irptc/sids/OECDSIDS/108805.pdf.
53. Ogasawara H., Imaida K., Ishiwata H., Toyoda K., Kawanishi T., Uneyama C., Hayashi S., Takahashi M., Hayashi Y. Urinary bladder carcinogenesis induced by melamine in F344 male rats: correlation between carcinogenicity and urolith formation. Carcinogenesis 1995, 16(11):2773-2777.
54. Okumura M., Hasegawa R., Shirai T., Ito M., Yamada S., Fukushima S. Relationship between calculus formation and carcinogenesis in the urinary bladder of rats administered the non-genotoxic agents thymine or melamine. Carcinogenesis 1992, 13(6):1043-1045.
55. Parry, J., 2008. China's Tainted milk scandal spreads around world. Br. Med. J. 337:a, 1890. Available at: (accessed 12.03.10). http://www.bmj.com/cgi/content/full/337/oct01_1/a1890.
56. Puschner B., Poppenga R.H., Lowenstine L.J., Filigenzi M.S., Pesavento P.A. Assessment of melamine and cyanuric acid toxicity in cats. J. Vet. Diag. Invest. 2007, 19(6):616-624.
57. Qing, T., 2008. FDA Announces Recalls of More Melamine Tainted Chinese Products. The Epoch Times. Available at: (accessed 18.02.09). http://www.theepochtimes.com/n2/content/view/4876/.
58. Reimschuessel R. A fish model of renal regeneration and development: review. ILAR J. 2001, 42(4):285-291.
59. Reimschuessel, R., Evans, E., Andersen, W.C., Turnipseed, S.B., Karbiwnyk, C.M., Mayer, T.D., Nochetto, C., Rummel, N.G., Gieseker, C.M., 2009. Residue depletion of melamine and cyanuric acid in catfish and rainbow trout following oral administration. J. Vet. Pharmacol. Ther. 33(2), 172-182. Available at: (accessed 12.03.10). http://www3.interscience.wiley.com/journal/122498253/abstract.
60. Reimschuessel R., Gieseker C.M., Miller R.A., Ward J., Boehmer J., Rummel N., Heller D.N., Nochetto C., De Alwis G.K., Bataller N., Andersen W.C., Turnipseed S.B., Karbiwnyk C.M., Satzger R.D., Crowe J.B., Reinhard M.K., Roberts J.F., Witkowski M.R. Evaluation of the renal effects of experimental feeding of melamine and cyanuric acid to fish and pigs. Am. J. Vet. Res. 2008, 69(9):1217-1228.
61. Reimschuessel, R., Hattan D.G., Gu, Y., 2008b. Background Paper on Toxicology of Melamine and Its Analogues, prepared for Expert Meeting to Review Toxicological Aspects of Melamine and Cyanuric Acid. Health Canada, Ottowa, Canada, 1-4 December 2008. Available at: (accessed 12.03.10). http://www.who.int/foodsafety/fs_management/Melamine_5.pdf.
62. Reimschuessel, R., Stewart, L., Squibb, E., Hirokawa, K., Brady, T., Brooks, B., Shaikh, B., Hodsdon, C., 2008c. Phish-Pharm-2008. Available at: (accessed 12.03.10). http://www.fda.gov/AnimalVeterinary/ScienceResearch/ToolsResources/Phish-Pharm/default.htm.
63. Reimschuessel, R., Stewart, L., Squibb, E., Hirokawa, K., Brady, T., Brooks, B., Shaikh, B., Hodsdon, C., 2005. Fish drug analysis-phish-pharm: a searchable database of pharmacokinetics data in fish. AAPS J. 7(2), E288-E327. Available at: (accessed 12.03.10). http://www.aapsj.org/view.asp?art=aapsj070230.
64. Reyers, F., 2007. Melamine-contaminated pet food. The South African experience. Vet. News (May issue), 8-12.
65. Reyers F. Alert (Heads-up) message for South African Veterinary Livestock Health and Production Group. Melamine contamination of fresh milk in South Africa - Dairy meal adulteration. Livestock Health Prod. Rev. 2008, 8:4-5.
66. Schmale M.C., Nairn R.S., Winn R.N. Aquatic animal models of human disease. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 2007, 145(1):1-4.
67. Serota, D., Fezio, W., Hepner, K., et al., 1982. Thirteen-week Toxicity Study in Mice: Monosodium Isocyanurate: Project No. 2169-100. Final Report. (Submitted as unpublished report from Hazleton Laboratories America to WHO by the Industry Ad Hoc Committee on Isocyanurates).
68. Shaikh B., Rummel N., Gieseker C., Serfling S., Reimschuessel R. Metabolism and residue depletion of albendazole and its metabolites in rainbow trout, tilapia and Atlantic salmon after oral administration. J. Vet. Pharmacol. Ther. 2003, 26(6):421-427.
69. Shen Y., Liu X.R., Zhang G.J., Zhou N. Blood purification therapy in treatment of acute renal failure in infants with melamine-induced stones. Chin. Med. J. 2009, 122(3):257-261.
70. Sun, D.Q., Zhang, X.F., Zhang, L., Feng, H., Yang, Y.H., 2009. The clinical analysis of young children's urolithiasis due to melamine-tainted infant formula. World J. Urol. Available at: http://www.ncbi.nlm.nih.gov/sites/entrez.
71. Sun Q., Shen Y., Sun N., Zhang G.J., Chen Z., Fan J.F., Jia L.Q., Xiao H.Z., Li X.R., Puschner B. Diagnosis, treatment and follow-up of 25 patients with melamine-induced kidney stones complicated by acute obstructive renal failure in Beijing Children's Hospital. Eur. J. Pediatr. 2010, 169(4):483-489.
72. Sun N., Shen Y., Sun Q., Li X.R., Jia L.Q., Zhang G.J., Zhang W.P., Chen Z., Fan J.F., Jiang Y.P., Feng D.C., Zhang R.F., Zhu X.Y., Xiao H.Z. Melamine related urinary calculus and acute renal failure in infants. Chin. J. Pediatr. 2008, 46(11):810-815.
73. Talaat A.M., Reimschuessel R., Waserman S.S., Trucksis M. Mycobacterium marinum and the goldfish, Carassius auratus: a model system for mycobacterial pathogenesis. Infect. Immun. 1998, 66(6):2938-2942.
74. Thompson M.E., Lewin-Smith M.R., Kalasinsky V.F., Pizzolato K.M., Fleetwood M.L., McElhaney M.R., Johnson T.O. Characterization of melamine-containing and calcium oxalate crystals in three dogs with suspected pet food-induced nephrotoxicosis. Vet. Pathol. 2008, 45(3):417-426.
75. USFDA, 2007a. Available at: (accessed 12.03.10). http://www.fda.gov/animalveterinary/safetyhealth/recallswithdrawals/ucm129575.htm.
76. USFDA, 2007b. Available at: (accessed 12.03.10). http://www.fda.gov/AnimalVeterinary/SafetyHealth/RecallsWithdrawals/ucm129932.htm#AnimalFeed.
77. USFDA, 2007c. Interim Melamine and its Analogues Safety/Risk Assessment. Federal Register, 72, 30014-30015. Available at: (accessed 12.03.10). http://www.fda.gov/ScienceResearch/SpecialTopics/PeerReviewofScientificInformationandAssessments/ucm155012.htm.
78. USFDA, 2008. Interim Safety and Risk Assessment of Melamine and its Analogues in Food for Humans. Available at: and (accessed 12.03.10). http://www.fda.gov/Food/FoodSafety/FoodContaminantsAdulteration/ChemicalContaminants/Melamine/ucm164520.htm.
79. USFDA, 2009. Code of Federal Regulations Title 21, Part 58 Good Laboratory Practice for Nonclinical Laboratory Studies. Available at: (accessed 12.03.10). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=58&showFR=1.
80. Vernon S.E. Preservation of tissue urate crystals with the use of a rapid tissue-processing system. J. Histotechnol. 2006, 29(1):17-19.
81. Wang, X., Guo, J., Ruan, S., Lu, Y., Bi, Y., Xiao, X., Wang, G., 2009. Ureteroscopic lithotripsy for the treatment of urinary calculi in infants and young children. Urology 74(4) (Abstract # MP-12.15).
82. Wen J.G., Yang H., Wang Y., Wang G. The clinical analysis of urolithiasis in 165 infants and children with history of feeding melamine contaminated milk powder. J. Urolo. 2009, 181(4):380.
83. Wen, J.G., Li, Z.Z., Zang, H., Wang, Y, Wang, J.X., Fan, Y.Z., 2009b. The clinical analysis of double renal calculus in 50 infants and children fed melamine contaminated milk powder. J Urolo. 181(4), 380.
84. WHO, 2004. Food Additives Series No. 52, Safety Evaluation of Certain Food Additives and Contaminants: Sodium Dichloroisocyanurate. The sixty-first Meeting of the Joint FAO/WHO Expert Committee on Food Additives, Rome, Italy, 10-19 June 2003, World Health Organization, Geneva. Available at: (accessed 12.03.10). http://whqlibdoc.who.int/publications/2004/924166052X.pdf.
85. WHO, 2008. Expert Meeting to Review Toxicological Aspects of Melamine and Cyanuric Acid. Available at: and and (accessed 07.03.10). http://www.who.int/foodsafety/fs_management/infosan_events/en/index.html.
86. Wong S.N., Chiu M.C. The scare of melamine tainted milk products. Hong Kong J. Paediatr. 2008, 13(4):230-234.
87. Xin H., Stone R. Chinese probe unmasks high-tech adulteration with melamine. Science 2008, 322(5906):1310-1311.
88. Yarlagadda S.G., Perazella M.A. Drug-induced crystal nephropathy: an update. Expert Opinion Drug Saf. 2008, 7(2):147-158.